Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

ZURA

Zura Bio (ZURA)

Zura Bio Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ZURA
일자시간출처헤드라인심볼기업
2024/05/0919:00Business WireZura Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
2024/04/1822:22Business WireZura Bio Announces Oversubscribed $112.5 Million Private PlacementNASDAQ:ZURAZura Bio Ltd
2024/04/0819:00Business WireZura Bio Announces Robert Lisicki as CEO and DirectorNASDAQ:ZURAZura Bio Ltd
2024/03/2819:00Business WireZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerNASDAQ:ZURAZura Bio Ltd
2024/03/0420:00Business WireZura Bio Announces Participation at March ConferencesNASDAQ:ZURAZura Bio Ltd
2024/02/2406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2024/02/1423:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZURAZura Bio Ltd
2024/02/0220:00Business WireZura Bio Announces Participation at February Investor ConferencesNASDAQ:ZURAZura Bio Ltd
2024/01/2701:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
2024/01/2701:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
2024/01/2701:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
2024/01/1207:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2024/01/0820:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2024/01/0820:00Business WireZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMONASDAQ:ZURAZura Bio Ltd
2024/01/0320:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2024/01/0320:00Business WireZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitNASDAQ:ZURAZura Bio Ltd
2023/12/0420:00Business WireZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNASDAQ:ZURAZura Bio Ltd
2023/11/1807:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
2023/11/1420:00Business WireZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNASDAQ:ZURAZura Bio Ltd
2023/11/1320:30Business WireZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
2023/10/2605:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2023/10/0310:54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
2023/10/0310:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2023/09/1513:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZURAZura Bio Ltd
2023/09/1506:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZURAZura Bio Ltd
2023/09/1505:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
2023/09/1218:00Business WireZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteNASDAQ:ZURAZura Bio Ltd
2023/08/2510:54Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
2023/08/1420:00Business WireZura Bio Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
2023/08/1206:13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
 검색 관련기사 보기:NASDAQ:ZURA